| Revenue growth | ₹456.5 Cr in Q2, ₹867.5 Cr for H1 FY27. |
|---|---|
| Margins | EBITDA margin stable; Dombivli improved to -₹20 Lakhs vs -₹9.5 Cr. |
| Demand visibility | Strong seasonal demand in Q2; Dombivli occupancy at 35%. |
| Management confidence | Confident, focused on organic ramp-up and strategic land acquisitions. |
Growth
Revenue grew significantly, supported by a sharp turnaround in the Dombivli hospital, which achieved near-EBITDA breakeven.
Outlook
Ongoing expansion projects at Pune South, Mira Road, and BKC are in regulatory or planning stages.
Risks
Potential regulatory caps on medicine margins and hospital billing practices could impact future profitability.
Last quarter's promises, checked
Delivered
- Dombivli loss guided ₹2-3Cr/mth → Q2 EBITDA -₹20L (= BEAT; period basis unstated)
- Q2 seasonally stronger → Q2 rev ₹456.5Cr vs Q1 ₹411Cr (= BEAT)
Partly delivered
- Dombivli breakeven in 1.5-2 yrs → -₹20L, not yet breakeven (= PARTIAL)
- Dombivli radiation/LINAC by year-end → no Q2 update (= PARTIAL, unverified)
- 3 projects on track, 5-yr delivery → Pune South, Mira Road, BKC still regulatory/planning (= PARTIAL)
Missed
- Debt only at capex-cycle end, accruals fund build → ₹500Cr term loan secured mid-capex (= MISS)
Earnings Call Transcript filed with NSE, NSE: JLHL. Summary written with AI assistance from the document.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹256.75
- Market cap
- ₹8,417 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 45.1×Sector 52.0×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Acquisition Worth ₹150 Cr
Jupiter Life Line Hospitals executed a sale agreement to acquire 11,452.07 sq m of land in Pune for Rs 150 Crore. The land is where its South Pune hospital project is under development.
- Value
- ₹150.0 Cr
Jupiter Life Line Hospitals Capacity Expansion: ₹0.01 Cr Investment
Jupiter Life Line Hospitals will hold 100% of newly incorporated subsidiary Holitti Private Limited, a healthcare services entity. The subscription is for paid-up capital of Rs 1,00,000, about Rs 0.01 Crore.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Merger & Restructuring Worth ₹0.01 Cr
Jupiter Life Line Hospitals will incorporate wholly owned subsidiary Holitti Private Limited for healthcare services, subscribing Rs 1 lakh. It will run laboratory and healthcare services.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 436.3 cr (+15.8% YoY), EBITDA Rs 106.9 cr (23.4% margin), PAT Rs 56.4 cr (-1.7%) on Dombivli ramp-up, depreciation and finance costs. Bed capacity expanding from 1,700 to 2,900.
Jupiter Life Line Hospitals Q2 FY27 Results: Net Profit ₹56.4 Cr, Down 1.9% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹456.5 Cr (+16.0% YoY) and net profit of ₹56.4 Cr (-1.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.4 Cr · -1.9% YoY
Jupiter Life Line Hospitals Debt & Borrowing: ₹500 Cr
Jupiter Life Line Hospitals secured a Rs. 500 Crore term loan from HDFC Bank for capital expenditure, including a Rs. 300 Crore LC sublimit.
- Value
- ₹500.0 Cr